319 related articles for article (PubMed ID: 11329233)
1. Effects of hormone replacement therapy on serum lipids in elderly women. a randomized, placebo-controlled trial.
Binder EF; Williams DB; Schechtman KB; Jeffe DB; Kohrt WM
Ann Intern Med; 2001 May; 134(9 Pt 1):754-60. PubMed ID: 11329233
[TBL] [Abstract][Full Text] [Related]
2. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study.
Downs JR; Clearfield M; Weis S; Whitney E; Shapiro DR; Beere PA; Langendorfer A; Stein EA; Kruyer W; Gotto AM
JAMA; 1998 May; 279(20):1615-22. PubMed ID: 9613910
[TBL] [Abstract][Full Text] [Related]
3. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial.
JAMA; 1995 Jan; 273(3):199-208. PubMed ID: 7807658
[TBL] [Abstract][Full Text] [Related]
4. Effect of combination therapy with lipid-reducing drugs in patients with coronary heart disease and "normal" cholesterol levels. A randomized, placebo-controlled trial. Harvard Atherosclerosis Reversibility Project (HARP) Study Group.
Pasternak RC; Brown LE; Stone PH; Silverman DI; Gibson CM; Sacks FM
Ann Intern Med; 1996 Oct; 125(7):529-40. PubMed ID: 8815751
[TBL] [Abstract][Full Text] [Related]
5. Effects of endurance exercise and hormone replacement therapy on serum lipids in older women.
Binder EF; Birge SJ; Kohrt WM
J Am Geriatr Soc; 1996 Mar; 44(3):231-6. PubMed ID: 8600189
[TBL] [Abstract][Full Text] [Related]
6. Effects of different hormone replacement regimens on postmenopausal women with abnormal lipid levels. Menopause Study Group.
Pickar JH; Wild RA; Walsh B; Hirvonen E; Lobo RA
Climacteric; 1998 Mar; 1(1):26-32. PubMed ID: 11913407
[TBL] [Abstract][Full Text] [Related]
7. Effects of continuous combined hormone-replacement therapy on lipid levels in hypercholesterolemic postmenopausal women.
Denke MA
Am J Med; 1995 Jul; 99(1):29-35. PubMed ID: 7598139
[TBL] [Abstract][Full Text] [Related]
8. Effects of a lipid lowering fibrate and hormone replacement therapy on serum lipids and lipoproteins in overweight postmenopausal women with elevated triglycerides.
Nerbrand C; Nyberg P; Nordström L; Samsioe G
Maturitas; 2002 May; 42(1):55-62. PubMed ID: 12020980
[TBL] [Abstract][Full Text] [Related]
9. Lipoprotein lipids in older people. Results from the Cardiovascular Health Study. The CHS Collaborative Research Group.
Ettinger WH; Wahl PW; Kuller LH; Bush TL; Tracy RP; Manolio TA; Borhani NO; Wong ND; O'Leary DH
Circulation; 1992 Sep; 86(3):858-69. PubMed ID: 1516198
[TBL] [Abstract][Full Text] [Related]
10. Hormone therapy in women in the menopause transition. Randomised, double-blind, placebo-controlled trial of effects on body weight, blood pressure, lipoprotein levels, antithrombin III activity, and the endometrium.
Khoo SK; Coglan MJ; Wright GR; DeVoss KN; Battistutta D
Med J Aust; 1998 Mar; 168(5):216-20. PubMed ID: 9539899
[TBL] [Abstract][Full Text] [Related]
11. The effects of different doses of medroxyprogesterone acetate on serum lipids, lipoprotein levels and atherogenic index in the menopausal period.
Aygen EM; Başbuğ M; Tayyar M; Kaya E
Gynecol Endocrinol; 1998 Aug; 12(4):267-72. PubMed ID: 9798136
[TBL] [Abstract][Full Text] [Related]
12. Low high-density lipoprotein cholesterol and other coronary heart disease risk factors in patients with total cholesterol levels greater than 5.17 mmol/L (200 mg/dL) in family practice. A report from CEN.
J Am Board Fam Pract; 1991; 4(5):285-97. PubMed ID: 1746296
[TBL] [Abstract][Full Text] [Related]
13. Estrogen and progestin, lipoprotein(a), and the risk of recurrent coronary heart disease events after menopause.
Shlipak MG; Simon JA; Vittinghoff E; Lin F; Barrett-Connor E; Knopp RH; Levy RI; Hulley SB
JAMA; 2000 Apr; 283(14):1845-52. PubMed ID: 10770146
[TBL] [Abstract][Full Text] [Related]
14. Serum lipids and incidence of coronary heart disease. Findings from the Systolic Hypertension in the Elderly Program (SHEP).
Frost PH; Davis BR; Burlando AJ; Curb JD; Guthrie GP; Isaacsohn JL; Wassertheil-Smoller S; Wilson AC; Stamler J
Circulation; 1996 Nov; 94(10):2381-8. PubMed ID: 8921777
[TBL] [Abstract][Full Text] [Related]
15. Lipid changes on hormone therapy and coronary heart disease events in the Heart and Estrogen/progestin Replacement Study (HERS).
Shlipak MG; Chaput LA; Vittinghoff E; Lin F; Bittner V; Knopp RH; Hulley SB;
Am Heart J; 2003 Nov; 146(5):870-5. PubMed ID: 14597937
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of the addition of ezetimibe to ongoing statin therapy in modifying lipid profiles and attaining low-density lipoprotein cholesterol goals in older and elderly patients: subanalyses of data from a randomized, double-blind, placebo-controlled trial.
Pearson T; Denke M; McBride P; Battisti WP; Brady WE; Palmisano J
Am J Geriatr Pharmacother; 2005 Dec; 3(4):218-28. PubMed ID: 16503317
[TBL] [Abstract][Full Text] [Related]
17. Effects of hormonal replacement therapy on lipid and haemostatic factors in post-menopausal ESRD patients.
Park JS; Jung HH; Yang WS; Kim SB; Min WK; Chi HS
Nephrol Dial Transplant; 2000 Nov; 15(11):1835-40. PubMed ID: 11071974
[TBL] [Abstract][Full Text] [Related]
18. Effect of conjugated equine estrogen in combination with two different progestogens on the risk factors of coronary heart disease in postmenopausal Chinese women in Taiwan: a randomized one-year study.
Chang TC; Lien YR; Chen M; Cheng SP; Chen RJ; Chow SN
Acta Obstet Gynecol Scand; 2004 Jul; 83(7):661-6. PubMed ID: 15225192
[TBL] [Abstract][Full Text] [Related]
19. Long-term vitamin D3 supplementation may have adverse effects on serum lipids during postmenopausal hormone replacement therapy.
Heikkinen AM; Tuppurainen MT; Niskanen L; Komulainen M; Penttilä I; Saarikoski S
Eur J Endocrinol; 1997 Nov; 137(5):495-502. PubMed ID: 9405029
[TBL] [Abstract][Full Text] [Related]
20. [Lipid risk factors of coronary heart disease during longterm observation of a Warsaw Pol-Monica population-based cohort].
Chotkowska E; Jasiński B; Kupść W; Broda G
Pol Arch Med Wewn; 1997 Jan; 97(1):37-46. PubMed ID: 9235550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
